The Vk*MYC Mouse Model of Myeloma Identifies Successful Combination Therapies for the Treatment of Bortezomib Refractory Myeloma Patients

被引：1
|
作者：
Chesi, Marta [1 ]
Palmer, Stephen [1 ]
Garbitt, Victoria [1 ]
Bergsagel, P. Leif
机构：
[1] Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
10.1182/blood.V116.21.3015.3015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1242 / 1242
页数：1
相关论文
共 50 条
  • [1] Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model
    Stessman, Holly A. F.
    Baughn, Linda B.
    Sarver, Aaron
    Xia, Tian
    Deshpande, Raamesh
    Mansoor, Aatif
    Walsh, Susan A.
    Sunderland, John J.
    Dolloff, Nathan G.
    Linden, Michael A.
    Zhan, Fenghuang
    Janz, Siegfried
    Myers, Chad L.
    Van Ness, Brian G.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 1140 - 1150
  • [2] PATHOPHYSIOLOGY OF ANEMIA IN THE VK*MYC MOUSE MODEL OF MULTIPLE MYELOMA
    Campanella, A.
    Bordini, J.
    Bertilaccio, S.
    Fermo, I.
    Ponzoni, M.
    Camaschella, C.
    HAEMATOLOGICA, 2014, 99 : 179 - 180
  • [3] Bortezomib in combination with thalidomide and dexamethasone - a successful treatment regimen in refractory extramedullary multiple myeloma
    Dytfeld, Dominik
    Matuszak, Magdalena
    Lewandowski, Krzysztof
    Komarnicki, Mieczyslaw
    ANNALS OF HEMATOLOGY, 2008, 87 (03) : 253 - 254
  • [4] Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma
    Dominik Dytfeld
    Magdalena Matuszak
    Krzysztof Lewandowski
    Mieczysław Komarnicki
    Annals of Hematology, 2008, 87 : 253 - 254
  • [5] Bortezomib in combination with bendamustine and preduisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, Wolfram
    Bourgeois, Malvina
    Wang, Song-Yau
    Heyn, Simone F.
    Jaekel, Nadja
    Braunert, Leanthe
    Rohrberg, Robert
    Hurtz, Hans Juergen
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Becker, Cornelia
    Al Ali, Haifa
    Niederwieser, Dietger W.
    BLOOD, 2007, 110 (11) : 799A - 800A
  • [6] BORTEZOMIB IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF ELDERLY PATIENTS AFFECTED BY REFRACTORY MULTIPLE MYELOMA
    Villa, M. R.
    Lucania, A.
    Esposito, M.
    Della Cioppa, P.
    Improta, S.
    Russolillo, S.
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 621 - 621
  • [7] Bendamustine and prednisone in combination with Bortezomib in the treatment of patients with relapsed/refractory multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Heyn, S.
    Wagner, I
    Jaekel, N.
    Rohrberg, R.
    Hurtz, H. -J.
    Schmalfeld, M.
    Assmann, M.
    Edelmann, T.
    Mohren, M.
    Hoffmann, F. A.
    Schwarzer, A.
    Hensel, G.
    Loeschke, K.
    Becker, C.
    Krahl, R.
    Al-Ali, H. K.
    Niederwieser, D.
    ONKOLOGIE, 2012, 35 : 144 - 144
  • [8] Bortezomib in combination with bendamustine and prednisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Wang, S. Y.
    Heyn, S.
    Jaekel, N.
    Al Ali, H.
    Niederwieser, D.
    ONKOLOGIE, 2008, 31 : 136 - 136
  • [9] Bortezomib in relapsed or refractory myeloma patients
    Leonetti Crescenzi, S.
    Piccioni, A. L.
    Bagnato, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 208 - 208
  • [10] BORTEZOMIB PLUS DEXAMETHASONE IN COMBINATION WITH MELPHALAN OR CYCLOPHOSPHAMIDE IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Tsirigotis, P.
    Girkas, K. G.
    Giannopoulou, V.
    Chondropoulos, S.
    Ioannidou, E.
    Papaxoinis, G.
    Pappa, V.
    Vasilatou, D.
    Dimoula, K.
    Kapodistrias, N.
    Papageorgiou, E.
    Economopoulos, T.
    Dervenoulas, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 436 - 436
12345